Expression of Matrix Metalloproteinases and Tissue Inhibitor of Matrix Metalloproteinases in Non-Small-Cell Lung Cancer
Invasion and Metastasis · 1998
DOI: 10.1159/000024506 ↗Kurz gefasst
Fachartikel in der Zeitschrift Invasion and Metastasis, 1998. Verfasst von M Suzuki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Institute of Pulmonary Cancer Research, Chiba University School of Medicine, Chiba, Japan. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Abstract (Originalsprache)
Expression of matrix metalloproteinase (MMP)-2, MMP-9, tissue inhibitor of metalloproteinases (TIMP)-1, and TIMP-2 was studied in non-small-cell lung cancer (NSCLC). Activity of MMP-2 and MMP-9 by gelatin zymography and expression of MMP-2, MMP-9, TIMP-1, and TIMP-2 mRNAs were examined in 11 lung cancer cell lines which included six small-cell lung cancer (SCLC) cell lines. Localization of MMP-2, MMP-9, TIMP-1, and TIMP-2 was examined by immunohistochemistry in 43 resected NSCLC (22 adenocarcinomas, 17 squamous cell carcinomas, 4 large cell carcinomas) using specific anti-human monoclonal antibodies. Expression of MMP-2 mRNA was detected in 5 (100%), MMP-9 in 1 (20%), TIMP-1 in 4 (80%), and TIMP-2 in 5 (100%) of 5 NSCLC cell lines examined. MMP-2 gelatinolytic activity also was detected in all five NSCLC cell lines, whereas MMP-9 activity was detected in only one cell line. In 43 patients, MMP-2, MMP-9, TIMP-1, and TIMP-2 immunoreactivity was demonstrated in 19 (44%), 9 (21%), 15 (35%), and 29 (67%) excised tumors, respectively. All stromal fibroblasts in tumor samples stained positive for MMP-2. There was a correlation between TIMP-2 immunoreactivity and disease stage (42% stage I versus 88% stages II, III, and IV) (p = 0.0024). Both cancer cell lines and NSCLC tumor samples frequently expressed MMP-2, MMP-9, TIMP-1, and TIMP-2; MMP-2 in particular was highly expressed in malignant cells and surrounding fibroblasts. These findings suggest that MMP-2 plays a more important role in invasion of NSCLC than MMP-9 and that TIMP-2 may have clinical relevance in NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Institute of Pulmonary Cancer Research, Chiba University School of Medicine, Chiba, Japan.
Zitieren
APA
Suzuki, M., Iizasa, T., Fujisawa, T., Baba, M., Yamaguchi, Y., Kimura, H., & Suzuki, H. (1998). Expression of Matrix Metalloproteinases and Tissue Inhibitor of Matrix Metalloproteinases in Non-Small-Cell Lung Cancer. Invasion and Metastasis. https://doi.org/10.1159/000024506
Vancouver
Suzuki M, Iizasa T, Fujisawa T, Baba M, Yamaguchi Y, Kimura H, et al. Expression of Matrix Metalloproteinases and Tissue Inhibitor of Matrix Metalloproteinases in Non-Small-Cell Lung Cancer. Invasion and Metastasis. 1998. doi:10.1159/000024506
BibTeX
@article{Suzuki1998,
author = {Suzuki, M and Iizasa, T and Fujisawa, T and Baba, M and Yamaguchi, Y and Kimura, H and Suzuki, H},
title = {Expression of Matrix Metalloproteinases and Tissue Inhibitor of Matrix Metalloproteinases in Non-Small-Cell Lung Cancer},
journal = {Invasion and Metastasis},
year = {1998},
doi = {10.1159/000024506}
}
EUVIMED